ANNOUNCEMENT

MedCity CONVERGE July 9-10 in Philly gathers payers, providers, medtech, pharma, digital health, policymakers & more.

Rubin, Scott

Follow Rubin, Scott: Website |

Nektar Therapeutics plunges on FDA worries about heart risk of opioid constipation med

Nektar Therapeutics plunges on FDA worries about heart risk of opioid constipation med

November 12, 2012 3:42 pm by | 0 Comments

Shares of Nektar Therapeutics (NASDAQ: NKTR) have plunged on Monday after the FDA raised concerns that a class of opioid constipation medications may cause heart problems. The company said that ... Read more
Did the prospects for Affymax anemia drug make the biotech’s stock jump?

Did the prospects for Affymax anemia drug make the biotech’s stock jump?

October 9, 2012 4:38 pm by | 0 Comments

Despite a weak market environment on Tuesday, shares of small-cap biotech stock Affmax (NASDAQ: AFFY) are surging once again. Heading into the closing bell, the stock had added more than ... Read more
Third Point Capital hedge fund buys Atena, Cigna, United, Wellpoint stocks

Third Point Capital hedge fund buys Atena, Cigna, United, Wellpoint stocks

August 14, 2012 6:33 pm by | 0 Comments

Third Point Capital, the New York-based hedge fund run by Dan Loeb, released its second-quarter 13-F after the closing bell on Tuesday. This filing revealed Third Point's long equity holdings ... Read more